“Pharmacoepidemiology, Impacts of Anxiety Disorders and Anxiolytic Abuse before and During the COVID-19 Pandemic”. 2022. Research, Society and Development 11 (5): e36111528340. https://doi.org/10.33448/rsd-v11i5.28340.